Lumida
/ARDT
⌘K
Ardent Health Inc

Ardent Health Inc

ARDT
$10.15USD-0.49%-0.05 today

MARKET CAP

1.5B

P/E (TTM)

6.2x

FWD P/E

8.1x

DAY RANGE

$10 – $10

52W RANGE

$8
$15

AI Summary

Stalk
TrimMedium

ARDT remains in an early Stage 1 consolidation after a terminal decline, trading in a tight range beneath the declining 200 DMA and flat short EMAs. A recent Bullish Exhaustion pattern at the upper boundary signals waning upside momentum and failed breakout attempts. Medium-term bias is bearish, permitting only downside engagement, while short-term timing is neutral. Execution should be deferred, looking to trim into rallies toward resistance near the range highs and 200 DMA.

  • Q1’26 revenue rose 7% YoY to $1.6B; adjusted EBITDA jumped 26% to $124M
  • Opened four urgent care centers, scaling outpatient services amid rising demand
  • Weak profitability and dividend yield factors signal inconsistent returns
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Ardent Health Services, Inc. (NASDAQ: ARDN) is a leading healthcare provider operating a network of hospitals and outpatient facilities across the southern United States. The company focuses on delivering high-quality patient care with an emphasis on optimizing outpatient services while maintaining efficient operational practices. Ardent operates within a dynamic healthcare landscape characterized by the ongoing demand for both inpatient and outpatient services, driven by demographic trends and increasing care complexities. The organization aims to leverage its innovative technologies, including AI-assisted virtual care, to enhance operational efficiencies and patient outcomes.

Bull says

  • Q1’26 revenue rose 7% YoY to $1.6B; adjusted EBITDA jumped 26% to $124M
  • Opened four urgent care centers, scaling outpatient services amid rising demand
  • Impact Program on track for $55M in cost savings, boosting margins and efficiency
  • Ended Q1 with $610M cash, funding high-margin expansions and investments
  • Holds top share in midsize markets growing 2–3× faster than national average
  • Favorable earnings yield and low stock volatility indicate financial stability

Bear says

  • Weak profitability and dividend yield factors signal inconsistent returns
  • Professional fee growth remains high, squeezing operating margins
  • Medicaid funding changes could reduce EBITDA by $150–175M by 2035
  • $1.1B debt load may limit flexibility amid tighter regulations
  • Payroll timing creates ~$50M cash-flow headwind, hindering investments
  • High sensitivity to interest rates and oil prices raises macro risk

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-10-2026neutral

Transcript signals

Bull points

  • first quarter revenue of $1.6 billion represents an increase of 7% compared to the prior year.
  • Adjusted EBITDA for the first quarter increased 26% over the prior year to $124 million, with the associated margin expanding 110 basis points to 7.7%.
  • As a percent of revenue, SW&B improved 260 basis points compared to the prior year period, reflecting our focus on precision staffing and reducing reliance on contract labor.

Bear points

  • Cash used in operating activities during the first quarter was $60 million, compared to $25 million used in the first quarter of 2025, which benefited from the collection of business insurance proceeds related to our 2023 cybersecurity incident.
  • we continue to be mindful of various industry factors, including potential exchange disruption and macroeconomic conditions that could dampen consumer sentiment.
  • we did have a small incremental step up in our capital spend, and the majority of that is going to that growth inside of those core markets. but contemplated in the guidance that we gave out from a capital perspective.
Read full transcript analysis ›